the effects of a new alpha 2 agonist ( s 3341 or rilmenidine ) on blood pressure ( bp ) , glycemic control , lipid metabolism and renal function were investigated during a 16-week open study in 29 insulin-treated diabetic patients with mild to moderate hypertension .
C0598783
lipid metabolism
C0021641
insulin